Identification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers
ABSTRACT Background SET domain‐containing protein 4 (SETD4) is a histone methyltransferase that has been shown to modulate cell proliferation, differentiation, and inflammatory responses by regulating histone H4 trimethylation (H4K20me3). Previous reports have demonstrated its function in the quiesc...
Saved in:
Main Authors: | Yuyun Zhong, Ruiqi Wang, Zijie Huang, Zhaoting Hu, Bin Peng, Bin Chen, Liyue Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.70126 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis
by: Mi Zou, et al.
Published: (2024-12-01) -
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
by: Ryan T. Wagner, et al.
Published: (2025-02-01) -
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
by: Zhi-Xun Guo, et al.
Published: (2025-01-01) -
Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma
by: Hongqing Cai, et al.
Published: (2025-01-01) -
Comprehensive Analysis Identifies <i>THEMIS2</i> as a Potential Prognostic and Immunological Biomarker in Glioblastoma
by: Jianan Chen, et al.
Published: (2025-01-01)